Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Busy address KBO
51 other companies have their registered office at the same address; threshold 10.
Financials
Financial year 2024
CureVac Belgium from Ottignies-Louvain-la-Neuve, company number BE0781532859, closed financial year 2024 with a result of € 103,209 after tax. For that financial year CureVac Belgium recorded a gross margin of € 4.6 million and equity of € 310,441. Compared with financial year 2023, the result moved from € 117,896 to € 103,209. The company is profitable. The buffer is growing. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on August 1, 2025.
€ 310,441
▲ 50% vs 2023
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 103,209
▼ 12% vs 2023
Profit after tax over the fiscal year.
€ 446,990
▲ 44% vs 2023
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2024. Retained profit grew to € 248,941.
People and assets in 2024
13.1
▲ 1.2 vs 2023
Average over the fiscal year, from the social balance sheet.
€ 4.4 million
▲ 56% vs 2023
€ 332,700 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
Debts at end 2024
€ 1.5 million
▲ 50% vs 2023
Loans from banks and other lenders, long and short.
€ 46,816
▼ 13% vs 2023
Supplier invoices still open on the last day of the fiscal year.
€ 1.2 million
▲ 32% vs 2023
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | Change 2023 → 2024 | |
|---|---|---|---|---|
| Revenue | € 1,112,266 | - | - | |
| Gross margin | - | € 3,107,634 | € 4,592,797 | ▲ 48% |
| Profit after taxes | € -6,859 | € 117,896 | € 103,209 | ▼ 12% |
| Equity | € 54,641 | € 207,231 | € 310,441 | ▲ 50% |
| Total debts | € 1,393,024 | € 2,706,052 | € 3,465,218 | ▲ 28% |
| Cash | € 190,325 | € 311,063 | € 446,990 | ▲ 44% |
| Retained profit | € -6,859 | € 145,731 | € 248,941 | ▲ 71% |
| Bank debt | € 500,000 | € 1,000,000 | € 1,500,000 | ▲ 50% |
| Balance sheet total | € 1,447,665 | € 2,913,284 | € 3,775,659 | ▲ 30% |
| Employees (FTE) | 6.9 | 11.9 | 13.1 | ▲ 1.2 |
Key figures of CureVac Belgium, fiscal years 2022 to 2024, from the annual accounts filed with the National Bank of Belgium.The annual account for fiscal year 2025 has not been filed yet; it was expected before 31 July 2026.
What happened to CureVac Belgium?
What happened at CureVac Belgium in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- Arlène DERBAIX stepped down as director. NBB
- Marco RAU stepped down as director. NBB
- New annual accounts for financial year 2024: profit of € 103,209 (▼ 12% vs 2023). filed late Source: NBB ↗
- Arlène DERBAIX became a director. NBB
- New establishment in Ottignies-Louvain-la-Neuve. KBO
- Start of the company according to the CBE. KBO
- Marco RAU became a director. NBB
In short
From € 6,859 loss in 2022 to € 103,209 profit in 2024.
Paid € 241,026 in corporate taxes since 2022.
Best year ever: 2023, with € 117,896 profit.
On average € 350,600 of value added per employee in 2024.
A new publication or filing at CureVac Belgium? We notify you, reason included.
Follow CureVac BelgiumDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
The shares are held by CUREVAC AG (100%).
Directors
According to the 2024 annual accounts
Marco RAU
Director
since 2022 · until 2029
Arlène DERBAIX
Director
since 2024 · until 2030
Shareholders
100%
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Courbevoie 13
1348 Ottignies-Louvain-la-Neuve
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 51 companies are registered at this address.
All companies at this address →Union professionnelle belge des Agences de Voyages - Belgische Beroepsvereniging van Reisbureaus
SNPS Belgium
€ 9.3 million gross margin · 2025
INDUSTRYLED
€ 250,862 revenue · 2025
n-Side
€ 29.7 million revenue · 2025
FONDINVEST COMPANY
€ 291,949 gross margin · 2025
+46 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0781.532.859
- VAT number
- BE 0781.532.859
- Registered office
- Courbevoie 13, 1348 Ottignies-Louvain-la-Neuve
- Names & denominations
- CureVac Belgium
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 3 February 2022
- Peppol
- Active · Active since 27 Nov 2025
- Activities · NACE
Handelsbemiddeling in de groothandel in andere specifieke goederen
Speur- en ontwikkelingswerk op biotechnologisch gebied